Bolli P, Wood A J, Simpson F O
Clin Pharmacol Ther. 1976 Aug;20(2):138-41. doi: 10.1002/cpt1976202138.
A double-blind placebo crossover trail (2 periods, each of 6 wk) was carried out in 12 patients. In the first period the patients were randomly allocated to either their individual established dose of prazosin or to the same number of placebo tablets; treatment was reversed after 6 wk. Blood pressure was higher by 17/8 mm Hgin the lying posture and by 24/14 mm Hg in the standing posture during placebo than during prazosin treatment. Standing pulse rate and body weight were higher and plasma renin activity lower during prazosin treatment. Postural hypotension occurring 1 to 2 hr after the first few doses was noted in one third of the patients when they resumed prazosin treatment after the placebo course.
对12名患者进行了一项双盲安慰剂交叉试验(2个周期,每个周期6周)。在第一个周期,患者被随机分配到各自既定剂量的哌唑嗪或相同数量的安慰剂片;6周后治疗进行了互换。与哌唑嗪治疗期间相比,安慰剂治疗期间卧位血压高17/8 mmHg,立位血压高24/14 mmHg。哌唑嗪治疗期间,立位脉搏率和体重较高,血浆肾素活性较低。在安慰剂疗程后恢复哌唑嗪治疗时,三分之一的患者在最初几剂药物后1至2小时出现体位性低血压。